Efficacy of thalidomide in the treatment of VAD-refractory plasma cell leukaemia appearing after autologous stem cell transplantation for multiple myeloma

被引：14
|
作者：
Bauduer, F [1 ]
机构：
[1] Ctr Hosp Cote Basque, Hematol Serv, Bayonne, France
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2002年 / 117卷 / 04期
关键词：
thalidomide; plasma cell leukaemia; multiple myeloma;
D O I：
10.1046/j.1365-2141.2002.03537_4.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：996 / 997
页数：2
相关论文
共 50 条
  • [1] Thalidomide before autologous stem cell transplantation in VAD-refractory multiple myeloma patients
    Patriarca, F
    Sperotto, A
    Prosdocimo, S
    Geromin, A
    Zaja, F
    Fanin, R
    HAEMATOLOGICA, 2003, 88 (05) : 597 - 599
  • [2] Thalidomide before autologous stem cell transplantation in VAD-refractory multiple myeloma patients
    Patriarca, F
    Sperotto, A
    Prosdocimo, S
    Geromin, A
    Zaja, F
    Fili, C
    Cerno, M
    Fanin, R
    BONE MARROW TRANSPLANTATION, 2003, 31 : S78 - S79
  • [3] Thalidomide as salvage therapy for VAD-refractory multiple myeloma prior to autologous PBSCT
    Pitini, V
    Arrigo, C
    Aloi, G
    Micali, C
    La Gattuta, G
    BONE MARROW TRANSPLANTATION, 2003, 31 (11) : 1065 - 1065
  • [4] Myeloma - Thalidomide as salvage therapy for VAD-refractory multiple myeloma prior to autologous PBSCT
    Ahmad, I
    Islam, T
    Chanan-Khan, A
    Hahn, T
    Wentling, D
    Becker, JL
    McCarthy, PL
    Alam, AR
    BONE MARROW TRANSPLANTATION, 2002, 29 (07) : 577 - 580
  • [5] Thalidomide as salvage therapy for VAD-refractory multiple myeloma prior to autologous PBSCT
    I Ahmad
    T Islam
    A Chanan-Khan
    T Hahn
    D Wentling
    JL Becker
    PL McCarthy
    AR Alam
    Bone Marrow Transplantation, 2002, 29 : 577 - 580
  • [6] Thalidomide as salvage therapy for VAD-refractory multiple myeloma prior to autologous PBSCT
    V Pitini
    C Arrigo
    G Aloi
    C Micali
    G La Gattuta
    Bone Marrow Transplantation, 2003, 31 : 1065 - 1065
  • [7] Thalidomide plus VAD (vincristine, doxorabicin and dexamethasone) salvage therapy for VAD-refractory multiple myeloma, prior to autologous peripheral blood stem cell transplant (PBSCT).
    Ahmad, I
    Alam, AR
    Hahn, T
    Becker, J
    Chanan-Khan, AA
    Czuczman, M
    Bernstein, S
    Bernstein, Z
    McCarthy, P
    BLOOD, 2001, 98 (11) : 307B - 307B
  • [8] Thalidomide maintenance after autologous stem cell transplantation for multiple myeloma
    Grosskreutz, CL
    Egan, R
    Scigliano, E
    Fruchtman, SM
    Isola, LM
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 73 - 73
  • [9] Thalidomide maintenance after autologous stem cell transplantation for multiple myeloma.
    Grosskreutz, CL
    Egan, R
    Scigliano, E
    Fruchtman, SM
    Isola, LM
    BLOOD, 2003, 102 (11) : 489B - 490B
  • [10] Thalidomide as salvage therapy for VAD-refractory multiple myeloma prior to autologous PBSCT - Reply to the letter by V Pitini
    Alam, AR
    BONE MARROW TRANSPLANTATION, 2003, 31 (11) : 1067 - 1067
12345